These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 31007175)

  • 1. Outside the liver box: The gut microbiota as pivotal modulator of liver diseases.
    Wahlström A
    Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):912-919. PubMed ID: 31007175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The gut microbiome is important in chronic liver disease].
    Christensen E
    Ugeskr Laeger; 2019 Jan; 181(2):. PubMed ID: 30618372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota Targeted Approach in the Management of Chronic Liver Diseases.
    Liu J; Yang D; Wang X; Asare PT; Zhang Q; Na L; Shao L
    Front Cell Infect Microbiol; 2022; 12():774335. PubMed ID: 35444959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
    Arab JP; Martin-Mateos RM; Shah VH
    Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?
    Jiang L; Schnabl B
    Physiology (Bethesda); 2020 Jul; 35(4):261-274. PubMed ID: 32490750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota and liver diseases.
    Minemura M; Shimizu Y
    World J Gastroenterol; 2015 Feb; 21(6):1691-702. PubMed ID: 25684933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Gut Microbiota and the Hepatologist: Will Our Bugs Prove to be the Missing Link?
    Pallen MJ; Quraishi MN
    Dig Dis; 2017; 35(4):377-383. PubMed ID: 28468018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin A and liver diseases.
    Inamine T; Schnabl B
    J Gastroenterol; 2018 Jun; 53(6):691-700. PubMed ID: 29075899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage.
    Plaza-Díaz J; Solís-Urra P; Rodríguez-Rodríguez F; Olivares-Arancibia J; Navarro-Oliveros M; Abadía-Molina F; Álvarez-Mercado AI
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcoholic liver disease: the gut microbiome and liver cross talk.
    Hartmann P; Seebauer CT; Schnabl B
    Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?
    Brandl K; Schnabl B
    Expert Rev Gastroenterol Hepatol; 2015; 9(8):1069-76. PubMed ID: 26088524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional Communication between Liver and Gut during Alcoholic Liver Disease.
    Stärkel P; Schnabl B
    Semin Liver Dis; 2016 Sep; 36(4):331-339. PubMed ID: 27997973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal microbiota in liver disease.
    Haque TR; Barritt AS
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):133-42. PubMed ID: 27048904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intestinal microbiome and paediatric liver disease.
    Leung DH; Yimlamai D
    Lancet Gastroenterol Hepatol; 2017 Jun; 2(6):446-455. PubMed ID: 28497760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of gut microbiota in chronic liver diseases, and treatment possibilities].
    Hagymási K; Bacsárdi A; Egresi A; Berta E; Tulassay Z; Lengyel G
    Orv Hetil; 2018 Sep; 159(36):1465-1474. PubMed ID: 30175608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Gut Microbiota by Magnesium Isoglycyrrhizinate Mediates Enhancement of Intestinal Barrier Function and Amelioration of Methotrexate-Induced Liver Injury.
    Xia Y; Shi H; Qian C; Han H; Lu K; Tao R; Gu R; Zhao Y; Wei Z; Lu Y
    Front Immunol; 2022; 13():874878. PubMed ID: 35634319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of microbiota and related metabolites in gastrointestinal tract barrier function in NAFLD.
    Fernandez-Cantos MV; Garcia-Morena D; Iannone V; El-Nezami H; Kolehmainen M; Kuipers OP
    Tissue Barriers; 2021 Jul; 9(3):1879719. PubMed ID: 34280073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between the intestinal microbiome and liver diseases.
    Schnabl B; Brenner DA
    Gastroenterology; 2014 May; 146(6):1513-24. PubMed ID: 24440671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiome and liver disease.
    Betrapally NS; Gillevet PM; Bajaj JS
    Transl Res; 2017 Jan; 179():49-59. PubMed ID: 27477080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective.
    Wang L; Cao ZM; Zhang LL; Li JM; Lv WL
    Front Immunol; 2022; 13():923599. PubMed ID: 35911738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.